Bioadaptives Inc (BDPT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Bioadaptives Inc   (BDPT)
 

Bioadaptives Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bioadaptives Inc 's inventory turnover ratio, the ratio that measures Bioadaptives Inc 's ability to manage its supply chain, sequentially decreased to 0.14 in the second quarter 2026, which does not come as a surprise, as the Bioadaptives Inc continue to experience headwinds, which also impact its supply chain. Bioadaptives Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 2607 days, from 2147 days, in the Mar 31 2026 quarter.

Within Healthcare sector 375 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1785 in the first quarter 2026, to 1937.

BDPT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bioadaptives Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BDPT Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -8.91 % 5.87 % 133.88 % - 559.57 %
Y / Y Cost of Sales Growth -65.31 % - 1.6394543795509E+17 % - 776.42 %
Inventory Turnover Ratio (TTM) 0.14 0.17 0.14 0.08 0.09
BDPT's Total Ranking # 1937 # 1785 # 1789 # 1671 # 0
Average inventory processing period 2654 2179 2669 4458 4202
Seq. Inventory Growth -16.11 % -3.89 % 1.08 % 11.76 % -2.49 %
Seq. Cost of Sales Growth -46.61 % -50.74 % 264.15 % -63.78 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 120
Healthcare Sector # 376
Overall Market # 1937

Inventory Turnover Ratio Statistics
High Average Low
2.37 0.88 0
(Sep 30 2023)   (Mar 31 2019)



BDPT Company Profile >> Back to BDPT Efficiency Comparisons >> Compare BDPT Inventory Turnover Ratio to its Competitors

Financial Statements
Bioadaptives Inc 's Inventories $ 0 Millions Visit BDPT's Balance sheet
Bioadaptives Inc 's Cost of Revenues TTM $ 0 Millions Visit BDPT's Income Statement
What are BDPT's Sales? Visit BDPT's Sales by Segment

Other Inventory Turnover Ratios
Bioadaptives Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BDPT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BDPT's Competitors
Inventory Turnover Ratio for BDPT's Suppliers
Inventory Turnover Ratio for BDPT's Customers

You may also want to know
BDPT's Sales Growth Rates BDPT's Pe Price to earnings ratio BDPT's Receivables Turnover Ratio BDPT's Stock Quote
BDPT's Net Income Growth Rates BDPT's Ps Price to Sales ratio BDPT's Sales per Employee BDPT's Asset Turnover Ratio
BDPT's Net Margin BDPT's Pb Price to Book ratio BDPT's Financial Strength Ratios BDPT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Co diagnostics Inc   0.44 $ 0.412  Millions$ 1  Millions
Immunitybio inc   0.43 $ 1.095  Millions$ 3  Millions
Pelthos Therapeutics Inc   0.40 $ 9.271  Millions$ 23  Millions
EBR Systems, Inc.  0.39 $ 5.514  Millions$ 14  Millions
Aspire Biopharma Holdings Inc   0.34 $ 0.080  Millions$ 0  Millions
Guided Therapeutics Inc   0.32 $ 0.158  Millions$ 1  Millions
Invo Fertility Inc   0.29 $ 0.065  Millions$ 0  Millions
Outlook Therapeutics Inc   0.26 $ 0.985  Millions$ 4  Millions
Agios Pharmaceuticals Inc   0.23 $ 7.873  Millions$ 34  Millions
Alpha Cognition Inc.  0.23 $ 1.250  Millions$ 6  Millions
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Madrigal Pharmaceuticals Inc   0.12 $ 10.400  Millions$ 89  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Ptc Therapeutics inc   0.05 $ 3.600  Millions$ 75  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.